What happened
UnitedHealth Group (NYSE: UNH) reported third quarter 2026 results and raised full-year 2026 adjusted earnings guidance on October 13, 2026. Consolidated revenues were $112.7 billion. Earnings from operations were $6.6 billion. Net margin was 3.6%.
Diluted earnings were $4.56 per share. Adjusted earnings were $4.69 per share. The company now expects full-year 2026 adjusted net earnings of at least $20.50 per share. UnitedHealthcare served 48.3 million consumers and generated $86.3 billion of revenue. Optum cared for over 120 million patients and consumers and drove $66.9 billion of revenue.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Third quarter 2026 revenues | $112.7 billion | from $113.2 billion, -$0.5 billion | SEC 8-K |
| Third quarter 2026 earnings from operations | $6.6 billion | from $4.3 billion, + $2.3 billion | SEC 8-K |
| Third quarter 2026 net margin | 3.6% | from 2.1%, +1.5 percentage points | SEC 8-K |
| Third quarter 2026 adjusted earnings per share | $4.69 per share | from $2.92 per share, + $1.77 per share | SEC 8-K |
| Cash flows from operations | $5.1 billion | SEC 8-K | |
| Full-year 2026 adjusted net earnings outlook | At least $20.50 per share | SEC 8-K |
Why it matters
Cash flows from operations were $5.1 billion, or 1.2x net income. The debt-to-capital ratio was 41.7% as of September 30, 2026. Operating earnings rose $2.3 billion from $4.3 billion a year earlier. The operating cost ratio was 12.8%, compared with 13.5% in the third quarter 2025. MCR was 88.4% and included $610 million of net favorable prior period reserve development related to 2026 dates of service.
OptimistFi's case is that UnitedHealth's scale still turns revenue into cash and shareholder returns, and the raised outlook supports that view. The caveat is that Optum Health revenues of $22.9 billion decreased 10% year-over-year. That keeps the normalization question open for the services business. UnitedHealthcare earnings from operations were $2.8 billion, and Optum earnings from operations were $3.7 billion.
UnitedHealthcare revenues were $86.3 billion, while Optum revenues were $66.9 billion, keeping both businesses central to the quarter. The company repurchased $5.0 billion of common stock and paid $6.2 billion in dividends year-to-date.
Browse: stock research on every company OptimistFi covers
What's next
UnitedHealth Group will discuss the results, strategy and future outlook on a conference call with investors at 8:00 a.m. Eastern Time today. The webcast replay will remain on the Investor Relations page through October 27, 2026. Clearer signs that medical costs and Optum Health are stabilizing would strengthen the case, while further pressure there would weaken it.
More from OptimistFi
- UNH stock: the UnitedHealth Group thesis, its status and the next test to watch
- Meta Platforms, Inc. (NASDAQ: META) Prices Muse Wonder for Developers
- American Superconductor Corporation (NASDAQ: AMSC) Revenue Rises as Margin Falls
- Levi Strauss & Co. (NYSE: LEVI) Raises Profit as Wholesale Outruns DTC
- Stock perps: Cerebras Systems perp's 11.1% drop exceeded several venues' liquidation moves
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC 8-K earnings release — UnitedHealth Group third quarter 2026 results and guidance update
- SEC 8-K exhibit 99.2 — Companion earnings release text
Read the full OptimistFi thesis on UnitedHealth Group: https://optimistfi.com/stocks/UNH
See what would break the UnitedHealth Group thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full UnitedHealth Group investment case, its status and the next test to watch live on the UnitedHealth Group thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
